{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:12:14Z","timestamp":1784041934994,"version":"3.55.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Dublin, Trinity College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Medication-related hospital admission is a major contributor to preventable patient harm and healthcare burden worldwide. The relationship between age and medication-related hospital admission has not been comprehensively synthesised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the association between age and medication-related admission in adults and to provide research recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>MEDLINE (Ovid), EMBASE, Scopus, Web of Science, PsycINFO, CINAHL, Cochrane Library, and Global Health databases were searched from January 2000 to March 2025. Studies of adults reporting medication-related admission, providing data on participant age for an exposed and comparator group, published in English were included. Studies restricted to children were excluded. Selection through dual, independent title\/abstract screening and full-text assessment using predefined eligibility criteria. Disagreements resolved by third reviewer or consensus. Study quality assessed using Joanna Briggs Institute tool for systematic reviews addressing questions of prevalence. Findings were reported descriptively and two meta-analyses were performed. Risk ratios of experiencing medication-related admission by age group (16\u201364\u00a0years-old, 65+years-old) were pooled. Mean ages of those experiencing medication-related admission compared to another cause of admission were pooled. Prediction intervals and sub-group analyses were used to explain heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty studies, recruiting 210,514 participants, were included, with the majority judged as good quality. Thirteen studies exclusively recruited an older cohort, 30 studies were undertaken in Europe. Age data were variably described. The pooled risk ratio 1.64, (95% CI 1.15\u20132.35, K\u2009=\u200912, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200996%, n\u2009=\u200956,101) suggested adults\u2009\u2265\u200965\u00a0years had a higher risk of experiencing medication-related admission than younger adults (16\u201364\u00a0years). Studies undertaken in Africa had a higher effect size. The pooled mean difference (2.86\u00a0years, 95% CI\u2009\u2212\u20091.63\u20137.36;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.21, K\u2009=\u200910, I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200993%, n\u2009=\u200912,440) indicated no statistically significant difference in age between groups. Risk of bias judgement was a statistically significant contributor to heterogeneity. Prediction intervals for both meta-analyses were wide, suggesting that findings of future studies could differ significantly. The certainty of evidence, GRADE approach, was very low.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Age is an unreliable predictor for medication-related admission without accounting for confounding and context. Future research should consistently define age categories and better explore other risk factors for medication-related admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02167-3","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:23:09Z","timestamp":1780572189000},"page":"1267-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between age and medication-related hospital admission in adults: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Reema Mohammad","family":"Munshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eimear","family":"Ni Sheachnasaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Strugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folasade","family":"Olawoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Comiskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamasine","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"10","key":"2167_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00228-023-03552-x","volume":"79","author":"K Bennett","year":"2023","unstructured":"Bennett K, Cahir C, Sorensen J. Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study. Eur J Clin Pharmacol. 2023;79(10):1417\u201324. https:\/\/doi.org\/10.1007\/s00228-023-03552-x.","journal-title":"Eur J Clin Pharmacol"},{"key":"2167_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s11096-020-01040-1","volume":"42","author":"A Linkens","year":"2020","unstructured":"Linkens A, Milosevic V, Van Der Kuy P, et al. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42:1243\u201351. https:\/\/doi.org\/10.1007\/s11096-020-01040-1.","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"2167_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf231","volume":"54","author":"N Cosgrave","year":"2025","unstructured":"Cosgrave N, Frydenlund J, Beirne F, et al. Hospital admissions due to adverse drug reactions and adverse drug events in older adults: a systematic review. Age Ageing. 2025;54(8):afaf231.","journal-title":"Age Ageing"},{"issue":"2","key":"2167_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.12293","volume":"78","author":"A Al Hamid","year":"2014","unstructured":"Al Hamid A, Ghaleb M, Aljadhey H, et al. A systematic review of hospitalization resulting from medicine\u2010related problems in adult patients. Br J Clin Pharmacol. 2014;78(2):202\u201317.","journal-title":"Br J Clin Pharmacol"},{"key":"2167_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2017-007453","author":"P Mongkhon","year":"2018","unstructured":"Mongkhon P, Ashcroft DM, Scholfield CN, et al. Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies. BMJ Qual Saf. 2018. https:\/\/doi.org\/10.1136\/bmjqs-2017-007453.","journal-title":"BMJ Qual Saf"},{"issue":"12","key":"2167_CR6","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/pds.5122","volume":"29","author":"F Lghoul\u2010Oulad Sa\u00efd","year":"2020","unstructured":"Lghoul\u2010Oulad Sa\u00efd F, Hek K, Flinterman LE, et al. Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands. Pharmacoepidemiol Drug Saf. 2020;29(12):1659\u201368.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2167_CR7","first-page":"e217","volume":"60","author":"I Bayoumi","year":"2014","unstructured":"Bayoumi I, Dolovich L, Hutchison B, et al. Medication-related emergency department visits and hospitalizations among older adults. Can Fam Physician. 2014;60(4):e217\u201322.","journal-title":"Can Fam Physician"},{"issue":"16","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/DHPS.S455990","volume":"17","author":"SN Gebremariam","year":"2024","unstructured":"Gebremariam SN, Sema FD, Jara AG, et al. Medication-related hospital admission among patients admitted to the emergency ward at the University of Gondar, North West Ethiopia: a cross sectional study. Drug Healthc Patient Saf. 2024;17(16):75\u201388.","journal-title":"Drug Healthc Patient Saf"},{"issue":"3","key":"2167_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054778","volume":"12","author":"MB Demessie","year":"2022","unstructured":"Demessie MB, Berha AB. Prevalence and predictors of drug-related hospitalisation among patients visiting emergency departments of Addis Ababa city hospitals in Ethiopia: a multicentre prospective observational study. BMJ Open. 2022;12(3):e054778.","journal-title":"BMJ Open"},{"issue":"1","key":"2167_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. British J Clinic Pharma. 2004;57(1):6\u201314.","journal-title":"British J Clinic Pharma"},{"issue":"21","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002\u201312. https:\/\/doi.org\/10.1056\/NEJMsa1103053.","journal-title":"N Engl J Med"},{"issue":"17","key":"2167_CR12","first-page":"1890","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890\u20136.","journal-title":"Arch Intern Med"},{"key":"2167_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1029067","volume":"13","author":"C Cahir","year":"2023","unstructured":"Cahir C, Curran C, Walsh C, et al. Adverse drug reactions in an ageing PopulaTion (ADAPT) study: prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients. Front Pharmacol. 2023;13:1029067. https:\/\/doi.org\/10.3389\/fphar.2022.1029067.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/14740338.2021.1938539","volume":"20","author":"R Li","year":"2021","unstructured":"Li R, Curtis K, Zaidi STR, et al. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Expert Opin Drug Saf. 2021;20(10):1267\u201374.","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"2167_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, et al. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847\u201357.","journal-title":"Drug Saf"},{"key":"2167_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2025.12.009","author":"L Krogh","year":"2025","unstructured":"Krogh L, Carter S, Liu S, et al. Methods used to identify and classify medication-related admissions and readmissions to hospitals: a systematic review. Res Social Adm Pharm. 2025. https:\/\/doi.org\/10.1016\/j.sapharm.2025.12.009.","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"2167_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/jss.jss_50_22","volume":"49","author":"R Hadia","year":"2022","unstructured":"Hadia R, Joshi D, Bhil D, et al. Incidence of adverse drug reactions among elderly patients: a systematic review and meta-analysis. J Sci Soc. 2022;49(2):91\u2013102. https:\/\/doi.org\/10.4103\/jss.jss_50_22.","journal-title":"J Sci Soc"},{"key":"2167_CR18","unstructured":"Blum MR, Sallevelt BT, Spinewine A et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374."},{"issue":"4","key":"2167_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/ageing\/afaa072","volume":"49","author":"D O'Mahony","year":"2020","unstructured":"O\u2019Mahony D, Gudmundsson A, Soiza RL, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2020;49(4):605\u201314. https:\/\/doi.org\/10.1093\/ageing\/afaa072.","journal-title":"Age Ageing"},{"issue":"9","key":"2167_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008656","volume":"5","author":"F Moriarty","year":"2015","unstructured":"Moriarty F, Hardy C, Bennett K, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656.","journal-title":"BMJ Open"},{"issue":"1","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995\u20132010. BMC medi. 2015;13(1):74.","journal-title":"BMC medi"},{"issue":"3","key":"2167_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/XEB.0000000000000064","volume":"13","author":"S Moola","year":"2015","unstructured":"Moola S, Munn Z, Sears K, et al. Conducting systematic reviews of association (etiology): the Joanna Briggs Institute\u2019s approach. Int J Evid Based Healthc. 2015;13(3):163\u20139. https:\/\/doi.org\/10.1097\/XEB.0000000000000064.","journal-title":"Int J Evid Based Healthc"},{"key":"2167_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https:\/\/doi.org\/10.1016\/j.ijsu.2021.105906.","journal-title":"Int J Surg"},{"issue":"4","key":"2167_CR24","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1007\/s11192-020-03820-y","volume":"126","author":"E Aboagye","year":"2021","unstructured":"Aboagye E, Jensen I, Bergstr\u00f6m G, et al. Investigating the association between publication performance and the work environment of university research academics: a systematic review. Scientometrics. 2021;126(4):3283\u2013301.","journal-title":"Scientometrics"},{"issue":"1","key":"2167_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0468-4","volume":"18","author":"Z Munn","year":"2018","unstructured":"Munn Z, Stern C, Aromataris E, et al. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):5. https:\/\/doi.org\/10.1186\/s12874-017-0468-4.","journal-title":"BMC Med Res Methodol"},{"key":"2167_CR26","unstructured":"World Health Organization (2017) Medication without Harm\u2014global patient safety challenge on medication safety. WHO\/HIS\/SDS\/2017.6, World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIS-SDS-2017.6."},{"key":"2167_CR27","unstructured":"Global burden of preventable medication-related harm in health care: a systematic review. Geneva: World Health Organization; 2023. Licence: CC\u00a0BY-NC-SA\u00a03.0\u00a0IGO. ISBN: 978-92-4-008888\u20137"},{"issue":"3","key":"2167_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/qshc.2006.017947","volume":"15","author":"HT Stelfox","year":"2006","unstructured":"Stelfox HT, Palmisani S, Scurlock C, et al. The \u201cTo Err is Human\u201d report and the patient safety literature. BMJ Qual Saf. 2006;15(3):174\u20138.","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"2167_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147\u201353. https:\/\/doi.org\/10.1097\/XEB.0000000000000054.","journal-title":"Int J Evid Based Healthc"},{"key":"2167_CR30","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2021.02.8109","author":"M Kirmayr","year":"2021","unstructured":"Kirmayr M, Quilodr\u00e1n C, Valente B, et al. The GRADE approach, Part 1: how to assess the certainty of the evidence. Medwave. 2021. https:\/\/doi.org\/10.5867\/medwave.2021.02.8109.","journal-title":"Medwave"},{"key":"2167_CR31","unstructured":"Chandler J, Cumpston M, Li T et al. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley, vol 1002. 2019. ISBN 9781119536611"},{"issue":"4","key":"2167_CR32","doi-asserted-by":"publisher","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65-W\u221294.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2167_CR33","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.14577","volume":"87","author":"AD Adedapo","year":"2021","unstructured":"Adedapo AD, Adedeji WA, Adedapo IA, et al. Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality. Br J Clin Pharmacol. 2021;87(4):1878\u201389.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2167_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/emermed-2012-201945","volume":"31","author":"F Ahern","year":"2014","unstructured":"Ahern F, Sahm LJ, Lynch D, et al. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study. Emerg Med J. 2014;31(1):24\u20139.","journal-title":"Emerg Med J"},{"issue":"7","key":"2167_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejim.2007.06.030","volume":"19","author":"A Alexopoulou","year":"2008","unstructured":"Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med. 2008;19(7):505\u201310.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"2167_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JRS-130596","volume":"25","author":"PA Alvarez","year":"2013","unstructured":"Alvarez PA, Bril F, Castro V, et al. Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina. Int J Risk Saf Med. 2013;25(3):185\u201392.","journal-title":"Int J Risk Saf Med"},{"issue":"10","key":"2167_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186631","volume":"12","author":"MT Angamo","year":"2017","unstructured":"Angamo MT, Curtain CM, Chalmers L, et al. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: a prospective cross-sectional study. PLoS ONE. 2017;12(10):e0186631.","journal-title":"PLoS ONE"},{"key":"2167_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/20420986231188842","volume":"14","author":"L Asio","year":"2023","unstructured":"Asio L, Nasasira M, Kiguba R. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors. Ther Adv Drug Saf. 2023;14:20420986231188842. https:\/\/doi.org\/10.1177\/20420986231188842.","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"2167_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-9-8","volume":"9","author":"M Brvar","year":"2009","unstructured":"Brvar M, Fokter N, Bunc M, et al. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009;9(1):1\u20138.","journal-title":"BMC Clin Pharmacol"},{"key":"2167_CR40","doi-asserted-by":"crossref","unstructured":"Cabr\u00e9 M, Elias L, Garcia M et al. Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit Analysis of 3292 patients. Med Clin (Barc) (English Edition). 2018;150(6):209\u2013214","DOI":"10.1016\/j.medcle.2018.01.003"},{"issue":"1","key":"2167_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PTS.0000000000000627","volume":"17","author":"S Dechanont","year":"2021","unstructured":"Dechanont S, Jedsadayanmata A, Butthum B, et al. Hospital admissions associated with medication-related problems in Thai older patients: a multicenter prospective observational study. J Patient Saf. 2021;17(1):15\u201322. https:\/\/doi.org\/10.1097\/PTS.0000000000000627.","journal-title":"J Patient Saf"},{"issue":"2","key":"2167_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","volume":"49","author":"K Fattinger","year":"2000","unstructured":"Fattinger K, Roos M, Verg\u00e8res P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol. 2000;49(2):158\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"2167_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00350","author":"C Giardina","year":"2018","unstructured":"Giardina C, Cutroneo PM, Mocciaro E, et al. Adverse drug reactions in hospitalized patients: results of the FORWARD (Facilitation of Reporting in Hospital Ward) study. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.00350.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2167_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11096-008-9240-5","volume":"30","author":"Y Hopf","year":"2008","unstructured":"Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci. 2008;30(6):854.","journal-title":"Pharm World Sci"},{"issue":"1","key":"2167_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-016-0109-9","volume":"6","author":"P-A Jolivot","year":"2016","unstructured":"Jolivot P-A, Pichereau C, Hindlet P, et al. An observational study of adult admissions to a medical ICU due to adverse drug events. Ann Intensive Care. 2016;6(1):1\u201312. https:\/\/doi.org\/10.1186\/s13613-016-0109-9.","journal-title":"Ann Intensive Care"},{"key":"2167_CR46","doi-asserted-by":"publisher","DOI":"10.4103\/2045-080X.123224","author":"M Karuppannan","year":"2013","unstructured":"Karuppannan M, Nee TK, Ali SM, et al. The prevalence of adverse drug event-related admissions at a local hospital in Malaysia. Arch Pharm Pract. 2013. https:\/\/doi.org\/10.4103\/2045-080X.123224.","journal-title":"Arch Pharm Pract"},{"issue":"1","key":"2167_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56855-z","volume":"14","author":"J Komagamine","year":"2024","unstructured":"Komagamine J. Prevalence of urgent hospitalizations caused by adverse drug reactions: a cross-sectional study. Sci Rep. 2024;14(1):6058.","journal-title":"Sci Rep"},{"issue":"8","key":"2167_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030515","volume":"9","author":"J Komagamine","year":"2019","unstructured":"Komagamine J, Kobayashi M. Prevalence of hospitalisation caused by adverse drug reactions at an internal medicine ward of a single centre in Japan: a cross-sectional study. BMJ Open. 2019;9(8):e030515.","journal-title":"BMJ Open"},{"issue":"8","key":"2167_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/phar.1287","volume":"33","author":"C Kongkaew","year":"2013","unstructured":"Kongkaew C, Hann M, Mandal J, et al. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy. 2013;33(8):827\u201337. https:\/\/doi.org\/10.1002\/phar.1287.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2167_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s002280050738","volume":"56","author":"R Lagnaoui","year":"2000","unstructured":"Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56(2):181\u20136.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2167_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bcp.15510","volume":"89","author":"ML Laroche","year":"2023","unstructured":"Laroche ML, Gautier S, Polard E, et al. Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT). Br J Clin Pharmacol. 2023;89(1):390\u2013400.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"2167_CR52","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0476","volume":"24","author":"AH Lavan","year":"2019","unstructured":"Lavan AH, O\u2019Mahony D, Buckley M, et al. Adverse drug reactions in an oncological population: prevalence, predictability, and preventability. Oncologist. 2019;24(9):e968. https:\/\/doi.org\/10.1634\/theoncologist.2018-0476.","journal-title":"Oncologist"},{"issue":"7","key":"2167_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220071","volume":"14","author":"M Lea","year":"2019","unstructured":"Lea M, Mowe M, Mathiesen L, et al. Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLoS ONE. 2019;14(7):e0220071.","journal-title":"PLoS ONE"},{"issue":"17","key":"2167_CR54","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/archinternmed.2008.3","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890\u20136. https:\/\/doi.org\/10.1001\/archinternmed.2008.3.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2167_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s41999-021-00580-7","volume":"13","author":"HM Luttikhuis","year":"2022","unstructured":"Luttikhuis HM, Blomaard LC, Van Der Kaaij MA, et al. Geriatric characteristics and the risk of drug-related hospital admissions in older Emergency Department patients. Euro Geriatric Medi. 2022;13(2):329\u201337.","journal-title":"Euro Geriatric Medi"},{"issue":"8","key":"2167_CR56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/gerona\/gls001","volume":"67","author":"ZA Marcum","year":"2012","unstructured":"Marcum ZA, Pugh MJV, Amuan ME, et al. Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans. J Gerontol A Biol Sci Med Sci. 2012;67(8):867\u201374. https:\/\/doi.org\/10.1093\/gerona\/gls001.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2167_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1532-5415.2011.03772.x","volume":"60","author":"ZA Marcum","year":"2012","unstructured":"Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. 2012;60(1):34\u201341.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2167_CR58","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s11096-021-01237-y","volume":"43","author":"M Ma\u0159\u00edkov\u00e1","year":"2021","unstructured":"Ma\u0159\u00edkov\u00e1 M, O\u010dovsk\u00e1 Z, Nerad V, et al. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic. Int J Clin Pharm. 2021;43(5):1218\u201326. https:\/\/doi.org\/10.1007\/s11096-021-01237-y.","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"2167_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/imj.12455","volume":"44","author":"C McLachlan","year":"2014","unstructured":"McLachlan C, Yi M, Ling A, et al. Adverse drug events are a major cause of acute medical admission. Intern Med J. 2014;44(7):633\u20138.","journal-title":"Intern Med J"},{"issue":"5","key":"2167_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.farma.2010.08.003","volume":"35","author":"CP Men\u00e9ndez-Conde","year":"2011","unstructured":"Men\u00e9ndez-Conde CP, Vicedo TB, Silveira ED, et al. Adverse drug reactions which provoke hospital admission. Farm Hosp (English Edition). 2011;35(5):236\u201343. https:\/\/doi.org\/10.1016\/j.farma.2010.08.003.","journal-title":"Farm Hosp (English Edition)"},{"issue":"1","key":"2167_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/pds.667","volume":"11","author":"T Mj\u00f6rndal","year":"2002","unstructured":"Mj\u00f6rndal T, Boman MD, H\u00e4gg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11(1):65\u201372.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2167_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003437","author":"JP Mouton","year":"2016","unstructured":"Mouton JP, Njuguna C, Kramer N, et al. Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa. Medicine Baltimore. 2016. https:\/\/doi.org\/10.1097\/MD.0000000000003437.","journal-title":"Medicine Baltimore"},{"key":"2167_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.899151","volume":"13","author":"Z O\u010dovsk\u00e1","year":"2022","unstructured":"O\u010dovsk\u00e1 Z, Ma\u0159\u00edkov\u00e1 M, Ko\u010d\u00ed J, et al. Drug-related hospital admissions via the department of emergency medicine: a cross-sectional study from the Czech Republic. Front Pharmacol. 2022;13:899151.","journal-title":"Front Pharmacol"},{"issue":"14","key":"2167_CR64","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2165\/00002018-200225140-00005","volume":"25","author":"P Olivier","year":"2002","unstructured":"Olivier P, Boulb\u00e9s O, Tubery M, et al. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice. Drug Saf. 2002;25(14):1035\u201344.","journal-title":"Drug Saf"},{"issue":"6","key":"2167_CR65","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00002512-200926060-00004","volume":"26","author":"P Olivier","year":"2009","unstructured":"Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department. Drugs Aging. 2009;26(6):475\u201382. https:\/\/doi.org\/10.2165\/00002512-200926060-00004.","journal-title":"Drugs Aging"},{"issue":"12","key":"2167_CR66","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2167_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00228-013-1630-5","volume":"70","author":"C Pedr\u00f3s","year":"2014","unstructured":"Pedr\u00f3s C, Quintana B, Rebolledo M, et al. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol. 2014;70(3):361\u20137.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2167_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","volume":"72","author":"C Pedr\u00f3s","year":"2016","unstructured":"Pedr\u00f3s C, Formiga F, Corbella X, et al. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features. Eur J Clin Pharmacol. 2016;72(2):219\u201326. https:\/\/doi.org\/10.1007\/s00228-015-1974-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7456","key":"2167_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ"},{"issue":"2","key":"2167_CR70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/pds.1663","volume":"18","author":"S Pourseyed","year":"2009","unstructured":"Pourseyed S, Fattahi F, Pourpak Z, et al. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf. 2009;18(2):104\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7241","key":"2167_CR71","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","volume":"320","author":"P Pouyanne","year":"2000","unstructured":"Pouyanne P, Haramburu F, Imbs JL. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ. 2000;320(7241):1036.","journal-title":"BMJ"},{"issue":"1","key":"2167_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S2173-5085(09)70064-4","volume":"33","author":"A Santamaria-Pablos","year":"2009","unstructured":"Santamaria-Pablos A, Redondo-Figuero C, Baena M, et al. Negative results related to drugs required in hospitalisation. Farm Hosp (English Edition). 2009;33(1):12\u201325.","journal-title":"Farm Hosp (English Edition)"},{"issue":"1","key":"2167_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0976-500X.77095","volume":"2","author":"H Singh","year":"2011","unstructured":"Singh H, Kumar BN, Sinha T, et al. The incidence and nature of drug-related hospital admission: a 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother. 2011;2(1):17.","journal-title":"J Pharmacol Pharmacother"},{"issue":"3","key":"2167_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40267-019-00700-1","volume":"36","author":"T Smeaton","year":"2020","unstructured":"Smeaton T, McElwaine P, Cullen J, et al. A prospective observational pilot study of adverse drug reactions contributing to hospitalization in a cohort of middle-aged adults aged 45\u201364 years. Drugs Ther Perspect. 2020;36(3):123\u201330. https:\/\/doi.org\/10.1007\/s40267-019-00700-1.","journal-title":"Drugs Ther Perspect"},{"issue":"6","key":"2167_CR75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12603-009-0237-0","volume":"14","author":"A Somers","year":"2010","unstructured":"Somers A, Robays H, Vander Stichele R, et al. Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging. 2010;14(6):477\u201382. https:\/\/doi.org\/10.1007\/s12603-009-0237-0.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"2167_CR76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS van der Hooft","year":"2008","unstructured":"van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction\u2010related hospitalisations: a population\u2010based cohort study. Pharmacoepidemiol Drug Saf. 2008;17(4):365\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2167_CR77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.6061\/clinics\/2014(03)03","volume":"69","author":"FR Varallo","year":"2014","unstructured":"Varallo FR, Capucho HC, da Silva Planeta C, et al. Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69(3):163\u20137.","journal-title":"Clinics"},{"issue":"3","key":"2167_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/pds.1154","volume":"15","author":"M von Euler","year":"2006","unstructured":"von Euler M, Eliasson E, \u00d6hl\u00e9n G, et al. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15(3):179\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2167_CR79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.archger.2008.01.004","volume":"48","author":"M Wawruch","year":"2009","unstructured":"Wawruch M, Zikavska M, Wsolova L, et al. Adverse drug reactions related to hospital admission in Slovak elderly patients. Arch Gerontol Geriatr. 2009;48(2):186\u201390.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"2167_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006376","volume":"5","author":"CP Kaufmann","year":"2015","unstructured":"Kaufmann CP, St\u00e4mpfli D, Hersberger KE, et al. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.","journal-title":"BMJ Open"},{"issue":"1","key":"2167_CR81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/tcrm.1.1.39.53597","volume":"1","author":"Y Koh","year":"2005","unstructured":"Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"2167_CR82","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.21037\/jtd.2018.01.134","volume":"10","author":"A Bertani","year":"2018","unstructured":"Bertani A, Di Paola G, Russo E, et al. How to describe bivariate data. J Thorac Dis. 2018;10(2):1133.","journal-title":"J Thorac Dis"},{"issue":"2","key":"2167_CR83","first-page":"79","volume":"5","author":"MA Pourhoseingholi","year":"2012","unstructured":"Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 2012;5(2):79.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"7","key":"2167_CR84","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/oem.2002.001115","volume":"62","author":"R McNamee","year":"2005","unstructured":"McNamee R. Regression modelling and other methods to control confounding. Occup Environ Med. 2005;62(7):500\u20136.","journal-title":"Occup Environ Med"},{"issue":"1","key":"2167_CR85","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010422","volume":"9","author":"A Sheikh","year":"2019","unstructured":"Sheikh A, Rudan I, Cresswell K, et al. Agreeing on global research priorities for medication safety: an international prioritisation exercise. J Glob Health. 2019;9(1):010422.","journal-title":"J Glob Health"},{"issue":"1","key":"2167_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","volume":"2","author":"EC Davies","year":"2007","unstructured":"Davies EC, Green CF, Mottram DR, et al. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf. 2007;2(1):79\u201387. https:\/\/doi.org\/10.2174\/157488607779315507.","journal-title":"Curr Drug Saf"},{"issue":"2","key":"2167_CR87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00228-018-2567-5","volume":"75","author":"N Falconer","year":"2019","unstructured":"Falconer N, Barras M, Martin J, et al. Defining and classifying terminology for medication harm: a call for consensus. Eur J Clin Pharmacol. 2019;75(2):137\u201345. https:\/\/doi.org\/10.1007\/s00228-018-2567-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"2167_CR88","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4843","author":"C Farmer","year":"2016","unstructured":"Farmer C, Fenu E, O\u2019Flynn N, et al. Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016. https:\/\/doi.org\/10.1136\/bmj.i4843.","journal-title":"BMJ"},{"issue":"6","key":"2167_CR89","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.294.6.716","volume":"294","author":"CM Boyd","year":"2005","unstructured":"Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716\u201324.","journal-title":"JAMA"},{"key":"2167_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108602","volume":"186","author":"JP Higgins","year":"2024","unstructured":"Higgins JP, Morgan RL, Rooney AA, et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186:108602.","journal-title":"Environ Int"},{"key":"2167_CR91","unstructured":"Wells GA, Shea B, O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"6","key":"2167_CR92","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s11096-019-00908-1","volume":"41","author":"A Ridge","year":"2019","unstructured":"Ridge A, Macintyre K, Kitsos A, et al. Assessing risk of adverse drug reactions in the elderly: a feasibility study. Int J Clin Pharm. 2019;41(6):1483\u201390.","journal-title":"Int J Clin Pharm"},{"key":"2167_CR93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11096-018-0768-8","volume":"41","author":"TG Kempen","year":"2019","unstructured":"Kempen TG, Hedstr\u00f6m M, Olsson H, et al. Assessment tool for hospital admissions related to medications: development and validation in older patients. Int J Clin Pharm. 2019;41:198\u2013206.","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02167-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:03:01Z","timestamp":1784041381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02167-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":93,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02167-3","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not required, as this study is based on previously published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}